Investing Profile

Dylan Morris

VCInvestor
Managing Director at Insight Partners
insightpartners.com/team/dyla...San Francisco Bay Area
Photo of Dylan Morris, Managing Director at Insight Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
899 CONNECTIONS
Insight Partners Network
231 CONNECTIONS
Caltech Network
66 CONNECTIONS
CRV Network
51 CONNECTIONS
Innovation Endeavors Network
37 CONNECTIONS
cb
Insight Partners Managing Director
$10.0M - $350.0M
$25.0M
20
$20B

Sign in to see all 11 investments on record.

Sign in with Google →
Board Director Exsilio Therapeutics2024 - Present
Board Director ImmuneBridge2023 - Present
Board Director Superluminal Medicines Inc.2023 - Present
Board Director DEM Biopharma, Inc.2022 - Present
Board Director Capacity Bio2022 - Present
Board Director Unlearn.AI2022 - Present
Board Director Profluent Bio2022 - Present
Board Director ArrePath2021 - Present
Managing Director Insight Partners2021 - Present
Board Director Switch Therapeutics2020 - Present
Board Observer Exo Therapeutics2019 - Present
Board Director Deciduous Therapeutics2019 - Present
Board Observer Plexium2018 - Present
Board Director Dyno Therapeutics2018 - Present
Board Director PhaseVPresent
Board Director ProfluentPresent
Board Director Averna TherapeuticsPresent
General Partner Charles River VenturesPresent
Board Director Unlearn.aiPresent
Board Director Gameto2022 - 2024
Board Observer NanoMosaic Inc.2021 - 2023
General Partner CRV2017 - 2021
Investment Team Innovation Endeavors2015 - 2017
Co-Founder Integrated Plasmonics Corporation2011 - 2014
Harvard University AB Computer Science
Caltech Graduate Research Biochemistry and Molecular Biophysics
Sign in with Google →
Sign in with Google →